HSV-1/2 Seronegativity and HCV Seropositivity in People Living with HIV Presenting at a Tertiary Care Teaching Hospital in Awka, Anambra State, Nigeria

Oketah E. N.

Virus and Genomics Research Unit, Department of Microbiology, University of Port Harcourt, Port Harcourt, Nigeria.

Frank-Peterside N.

Virus and Genomics Research Unit, Department of Microbiology, University of Port Harcourt, Port Harcourt, Nigeria.

Elechi C. R.

Virus and Genomics Research Unit, Department of Microbiology, University of Port Harcourt, Port Harcourt, Nigeria.

Ugwu C. H.

Virology Unit, Department of Applied Microbiology, Nnamdi Azikiwe University, Awka, Nigeria.

Onu E. N.

Department of Medical Microbiology, Faculty of Basic Clinical Medicine, Alex -Ekwueme Federal University Ndufu-Alike, Ikwo Ebonyi State, Nigeria.

Okonko B. J.

Virology and Immunology Unit, Department of Microbiology, Ebonyi State University, Abakaliki, Nigeria.

Igwe M. U.

Virus and Genomics Research Unit, Department of Microbiology, University of Port Harcourt, Port Harcourt, Nigeria.

Cookey T. I. *

Virus and Genomics Research Unit, Department of Microbiology, University of Port Harcourt, Port Harcourt, Nigeria.

Adim C. C.

Virus and Genomics Research Unit, Department of Microbiology, University of Port Harcourt, Port Harcourt, Nigeria.

Innocent-Adiele H. C.

Virus and Genomics Research Unit, Department of Microbiology, University of Port Harcourt, Port Harcourt, Nigeria.

Okerentugba P. O.

Virus and Genomics Research Unit, Department of Microbiology, University of Port Harcourt, Port Harcourt, Nigeria.

Okonko I. O.

Virus and Genomics Research Unit, Department of Microbiology, University of Port Harcourt, Port Harcourt, Nigeria.

*Author to whom correspondence should be addressed.


Abstract

Herpes simplex virus has public health importance as a leading cause of genital ulcers, which also facilitate human immunodeficiency virus while co-infection with hepatitis C virus and human immunodeficiency virus is common in certain populations. This study was carried out with the aim of determining the prevalence of Herpes simplex virus and hepatitis C virus in people living with HIV attending a teaching hospital in Awka, Anambra State, Nigeria. Blood samples were randomly collected from 100 HIV-infected individuals of which 42 were males and 58 were females and analysed using ELISA. Results showed an overall prevalence of HCV to be 4.0% seropositivity and HSV to be 0.0% with 100.0% seronegativity. Higher prevalence of HCV occurred in ages groups 26-35 years (4.7%) than 16-25 years (4.4%) and 36 years & above (4.0%) with a significant difference of p <0.05. It showed that HCV antibody was only present among females (6.9%) and target not detected (TND) with 4.4%. Higher prevalence of HCV occurred among HIV-infected individuals having CD4 counts of >350 cells/mm3 than the <200 cells/mm3 and 200-249 cells/mm3 (0.0%). The study showed 4.4% seropositivity of HCV and 100.0% seronegativity of HSV in HIV- infected individuals with the highest prevalence of HCV recorded for age boundary 26-35 years. Thus, the increased number of HCV seropositivity among HIV-infected individuals indicates that there is a synergistic relationship between HIV and HCV infection. This study recommends that more attention should be given to the area of HIV/HCV coinfection in the management of infected patients.

Keywords: HCV, HSV, seronegativity, seropositivity, PLWHA


How to Cite

Oketah E. N., Frank-Peterside N., Elechi C. R., Ugwu C. H., Onu E. N., Okonko B. J., Igwe M. U., Cookey T. I., Adim C. C., Innocent-Adiele H. C., Okerentugba P. O., and Okonko I. O. 2024. “HSV-1/2 Seronegativity and HCV Seropositivity in People Living With HIV Presenting at a Tertiary Care Teaching Hospital in Awka, Anambra State, Nigeria”. Asian Journal of Immunology 7 (1):21-30. https://doi.org/10.9734/aji/2024/v7i1126.

Downloads

Download data is not yet available.

References

Ouedraogo HG, Zida S, Sagna T, Zoure AA, Compaore RT, Soubeiga ST, Ouedraogo O, Kambiré D, Belemsaga/ Yugbaré D, Cissé K, Traoré Y, Barro N, Kouanda S. Herpes simplex virus type 2 (HSV-2) and its association with HIV, HCV, HBV, HTLV-1&2 and syphilis among men who have sex with men in Burkina Faso. Indian Journal of Medical Microbiology. 2023;42:59–64. Available:https://doi.org/10.1016/j.ijmmb.20 22.09.007

Chun HM, Carpenter RJ, Macalino GE, Crum-Cianflone NF. The role of sexually transmitted infections in hiv-1 progression: A Comprehensive Review of the Literature. Journal of sexually transmitted diseases. 2013;176459. Available:https://doi.org/10.1155/2013/176 459

Reward EE, Muo SO, Orabueze INA, Ike AC. Seroprevalence of herpes simplex virus types 1 and 2 in Nigeria: A systematic review and meta-analyses. Pathogens and global health. 2019;113(5):229–237. Available:https://doi.org/10.1080/20477724.2019.1678938

Birch S, Audsley J, Cros P, Goodman Z, McLean C, Mijch A, Lewin SR. HIV replication is associated with increased severity of liver biopsy changes in HIV-HBV and HIV-HCV co-infection. Journal of Medical Virology. 2019;84:993–1001.

Malary M, Abedi G, Hamzehgardeshi Z, Afshari M, Moosazadeh M. The prevalence of herpes simplex virus type 1 and 2 infection in Iran: A meta- analysis. International Journal of Reproductive Biomedicine. 2016;14(10):615–624.

Malkin JE. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes. 2004;11(Supp_1):S2A– 23A.

Pue B, Benet K. Management and treatment of chronic hepatitis C in HIV patients. Semin Liver Dis. 2019;32:138–46.

Anaedobe CG, Ajani TA. Sexual behavioural correlates of herpes simplex virus type 2 infections among pregnant women in South-western Nigeria. Inter J Com Med Pub Health. 2018;5:1274–1280.

Maier I, Wu GY. Hepatitis C and HIV co- infection: A review. World journal of gastroenterology. 2002;8(4):577–579. Available:https://doi.org/10.3748/wjg.v8.i4. 577

Akhtar A, Fatima S, Saeed H, Soo CT, Khan AH. HIV-HCV Coinfection: Prevalence and Treatment Outcomes in Malaysia. Intervirology. 2022;65(2):87–93. Available:https://doi.org/10.1159/00051883 6

Austin GE, Jensen B, Leete J, De L'Aune, W, Bhatnagar J, Racine M, Braun JE. Prevalence of hepatitis C virus seropositivity among hospitalized US veterans. The American Journal of the Medical Sciences. 2000;319(6):353–359. Available:https://doi.org/10.1097/00000441-200006000-00002

Rosenthal M, Castilho MC, Santos ICV, Moura MAS, Segurado AC. Low prevalence of hepatitis B virus, hepatitis D virus and hepatitis C virus among patients with human immunodeficiency virus or acquired immunodeficiency syndrome in the Brazilian Amazon basin. Rev Soc Bras Med Trop. 2019;39:519–22.

Munawwar A, Gupta S, Sharma SK, Singh S. Seroprevalence of HSV-1 and 2 in HIV- infected males with and without GUD: Study from a tertiary care setting of India. Journal of Laboratory Physicians. 2018;10(3):326–331. Available:https://doi.org/10.4103/JLP.JLP_7_18

Des Jarlais DC, Arasteh K, McKnight C, Hagan H, Perlman DC, Semaan S. Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: The current importance of sexual transmission of HIV. American Journal of Public Health. 2011;101(7):1277–1283. Available:https://doi.org/10.2105/AJPH.201 1.300130

Des Jarlais D, Semaan S. HIV and other sexually transmitted infections in injection drug users and crack cocaine smokers. : Holmes K, Sparling P, Stamm W, Piot P, Sexually Transmitted Diseases. New York: McGraw Hill. 2008;237–255

Des Jarlais D, Arasteh K, McKnight C, Hagan H, Perlman D, Friedman S. Using hepatitis C virus and herpes simplex virus- 2 to track HIV among injecting drug users in New York City. Drug Alcohol Depend. 2009;101(1–2):88–91.

Panayiotakopoulos GD, Mavroyianni D, Politou M, Aroni K, Kosmopoulou O, Kontos AN, Choremi-Papadopoulou H, Pediaditis J, Kordossis T. Human Herpesvirus-8 Seropositivity and Clinical Correlations in HIV-1–Positive and Highly Exposed, Persistently HIV-Seronegative Individuals in Greece. AIDS Patient Care & STDs. 2005;19(6):375-383.

Muhammad IA, Hafiz TR, Muhammad F, Rogo LD. Seroprevalence and Risk Factors of Herpes Simplex Virus Type-2 (HSV-2) Infection among HIV-Positive Patients in a Selected Teaching Hospital in Northern Nigeria. OIRT Journal of Medical and Health Sciences. 2021;1(2):51-55. Available:https://dx.doi.org/10.53944/ojmhs-2113

Alubi PC, Okonko BJ, Ogbuji CC, Mbah EI, Okonko IO. serological prevalence of herpes simplex virus, syphilis, and H. pylori Coinfections amongst HIV-infected individuals receiving care in a secondary healthcare facility in Port Harcourt, Nigeria. Journal of Multidisciplinary Research Updates (IJMRU). 2023;05(02): 001-016.

Gomaa HHA, SAS Hasan N, Harb AHA Gomaa, Anani M. Prevalence of herpes simplex virus in pregnant women in Ismailia city. Journal of Virological Sciences. 2022;10(1):18-26.

Al-Hakami AM, Paul E, Al-Abed F, Alzoani AA, Shati AA, Assiri MI, Chandramoorthy HC. prevalence of toxoplasmosis, rubella, cytomegalovirus, and herpes (TORCH) infections among women attending the antenatal care clinic, maternity hospital in Abha, Southwestern Saudi Arabia. Saudi Med. J. 2020;41(7):757. Available:https://doi.org/10.15537/smj.202 0.7.25121

Lima LR, Dos-Santos PJDS, De Almeida NA, De Meneses, MD, Aguiar SF, Fernandes CA, de Paula VS. Seroprevalence of human alphaherpes- virus 1 and 2 among pregnant women infected or uninfected with Zika virus from Rio de Janeiro, Brazil. J. Med. Virol. 2021; 93(6):3383-3388. Available:https://doi.org/10.1002/jmv.2666 5

Duran N, Serological evaluation of HSV-1 and HSV-2 infection in pregnancy. Turkish J. Med. Sci. 2004.34(2):97-101.

Okonko IO, Cookey TI, Okerentugba PO, Frank-Peterside N. Serum HSV-1 and -2 IgM in Pregnant Women in Port Harcourt, Nigeria, Journal of Immunoassay and Immunochemistry. 2015;36(4):343-358.

Okonko IO, Benjamin AF, Cookey TI, Okonko BJ, Innocent-Adiele HC. Prevalence of herpes simplex virus type- 2 IgG antibody among pregnant women in Port-Harcourt, Nigeria. Microbiologia Medica. 2023;38(1):10829,6-10.

Okonko IO, Awah A, Omang PA, Cookey TI, Okonko BJ, Onu EN, Oketah EN, Innocent-Adiele HC, Adim CC, Amadi BO. Serological evidence of herpes simplex virus type 2 IgM antibody among expectant mothers attending a tertiary healthcare facility in Port Harcourt, Nigeria. Asian Journal of Research in Nursing and Health. 2023;6(1);442–450.

Nag S, Sarkar S, Chattopadhya D, Bhattacharya S, Biswas R, SenGupta M. Seroprevalence of herpes simplex virus infection in HIV coinfected individuals in Eastern India with Risk Factor Analysis. Advances in Virology. 2015;7:537-539.

Hayatudeen MR, Mukhtar GL, Aminu M. Seroprevalence of immunoglubins G and M associated with herpes simplex virus type 2 among apparently healthy individuals in Katsina State, Nigeria. UMYU Journal of Microbiology Research. 2017;2(1):186-191.

Salman HJ, Chaloob FA, Al-Shuwaik, A M, Kadhim HS. Seroprevalence of herpes simplex virus type 2 IgG, IgM antibodies among hospitalized children under 5. years. Biochemical and Cellular Archives. 2018;8(1):161-167.

Okonko IO, Cookey TI. Seropositivity and determinants of immunoglobulin-G (IgG) antibodies against Herpes simplex virus (HSV) types -1 and -2 in pregnant women in Port Harcourt, Nigeria. Journal of African Health Science. 2015;15(3):737-747.

Irena Maier, George Y. Wu Hepatitis C and HIV co-infection. World J Gastroenterology. 2002;8(4):577–579.

Lacazari K, Amon JJ, Garfein RS, Ahdieh- Grant L, Armstrong GL, Ouellet LJ, Latka MH Prevalence of hepatitis C virus infection among injection drug users in the United States, Clin Infect Dis. 2017;46: 1852–8.

Elenwo M, Oketah EN, Okerentugba PO, Okonko IO. Coinfection of HCV among HIV-infected patients: A cross-sectional study in selected hospitals in Rivers State, Nigeria. International Journal of Science and Research Achieve. 2023; 10(1):758-763.

Okonko I, Ernest Nwagwu H. Serological Prevalence of Hepatitis C Virus among Febrile patients attending a General Hospital in Emohua LGA, Rivers State, Nigeria. Preprints. 2023;2023;030094. Available:https://doi.org/10.20944/preprints 202303.0094.v1

Ugwu CH, Oketah EN, Okerentugba PO, Frank-Peterside N, Okonko IO. Co- infection of HIV/Hepatitis C virus: A cross- sectional study from A University Teaching hospital in Anambra State, Nigeria. Magna Scientia Advanced Biology and Pharmacy (MSABP). 2023;09(01):001-007.

Alli JA, Okonko IO, Abraham OA, Kolade AF, Ogunjobi PI, Tonade OO, Ojezele MO, Nwanze JC. A serosurvey of blood parasites (Plasmodium, Microfilaria, HIV, HBsAg, HCV antibodies) in prospective Nigerian blood donors. Research Journal in Medical Sciences. 2010;4(4):255-275.

Okonko IO, Ikunga CV, Anugweje KC, Okerentugba PO. Anti-hepatitis C virus (HCV) antibody detection among fresh undergraduate students in Port Harcourt, Nigeria. Basic Sciences of Medicine. 2014;3(2):26-29.

Okonko IO, Biragbara MT, Cookey TI, Okonko BJ, Adim CC. Innocent-Adiele HC. Serological evidence of HBV, HCV and HEV infection among ART-Naïve HIV-1 infected individuals in a tertiary health facility in Port Harcourt, Nigeria, from 2016 – 2017. American Journal of Multidisciplinary Research and Development (AJMRD). 2023;5(04):48-57.

Cookey TI, Okonko IO, Frank-Peterside N. Zero Prevalence of HIV and HCV coinfection in the highly HIV-infected population of Rivers State, Nigeria. Asian Journal of Research in Medical and Pharmaceutical Sciences. 2021;10(3):9- 16.

Udeze AO, Ali UM, Adeoye PA, Odugbesi AE, Sule WF, Okonko IO. Hepatitis B and C seropositivity in a cohort of HIV-positive patients in Ilorin, North-central Nigeria. Nigerian Journal of Microbiology. 2015;28:2767-2776.

Okonko IO, Anugweje KC, Adeniji FO, Abdulyekeen RA. Syphilis and HIV, HCV and HBsAg coinfections among Sexually Active Adults. Nature and Science. 2012;10(1):66-74.

Ugwu CH, Oketah EN, Okoli UO, Okerentugba PO, Frank-Peterside N, Okonko IO. Serological prevalence of HCV/HIV co-infection among HIV- infected patients in Onitsha, Anambra State, Nigeria. International Journal of Multidisciplinary Research and Technology (IJMRT). 2023;4(6):74-84.

Aaron UU, Okonko IO, Frank-Peterside N. The Prevalence of Hepatis E, Hepatitis C and Hepatitis B surface antigenemias in HAART experienced people living with human immunodeficiency virus (HIV) in Rivers State, Nigeria. Journal of Biomedical Sciences. 2021;10(S4):001.

Okonko I, Adepoju A, Okerentungba P, Nwanze J, Onoh C. Detection of hepatitis c virus (HCV) antibody among children in Ibadan, Southwestern Nigeria. The Internet Journal of Gastroenterology. 2012;11(1).

Ojo DA, Akingbade OA, Okerentugba PO, Okonko IO. Prevalence of hepatitis C virus (HCV) seropositivity in a cohort of people living with HIV and AIDS in Abeokuta, Ogun State, Southwestern Nigeria. New York Science Journal. 2013;6(7):19-23.

Ogwu-Richard SA, Ojo DA, Akingbade OA, Okonko IO. Triple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria. African Health Sciences. 2015; 15(3):719-727.

Okonko IO, Cookey TI, Innocent-Adiele HC. Dual positivity of HIV and anti-HCV in the highly infected population of Rivers State, Nigeria. International Journal of Scientific Research Updates. 2022;04(02):039–048.

Ogbodo EN, Otue A, Okonko IO. Anti-HCV antibody among newly diagnosed HIV patients in Ughelli, a suburban area of Delta State Nigeria. African Health Sciences. 2015;15(3):728-736.

Dodig M, Tavill AS. Hepatitis C and human immunodeficiency virus coinfections. Journal of Clinical Gastroenterology. 2001;33(5):367–374. Available:https://doi.org/10.1097/00004836-200111000-00005

Yee HS, Currie SL, Darling JM, Wright TL. Department of veterans affairs hepatitis C resource center. Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office. The American Journal of Gastroenterology. 2006;101(10):2360– 2378. Available:https://doi.org/10.1111/j.1572- 0241.2006.00754.x

Alavi SM, Etemadi A. HIV/HBV, HIV/HCV and HIV/HTLV-1 co infection among injecting drug user patients hospitalized at the infectious disease ward of a training hospital in Iran. Pakistan Journal of Medical Sciences. 2007;23(4):510.

Ramezani A, Mohraz M, Gachkar L. Epidemiologic situation of human immunodeficiency virus (HIV/AIDS patients) in a private clinic in Tehran, Iran. Archives of Iranian Medicine. 2006; 9(4):315–318.

Tripathi AK, Khanna M, Gupta N, Chandra M. Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in Northern India. The Journal of the Association of Physicians of India. 2007;55:429–431.

Lesi OA, Kehinde MO, Oguh DN, Amira CO. Hepatitis B and C virus infection in Nigerian patients with HIV/AIDS. The Nigerian Postgraduate Medical Journal. 2007;14(2):129–133.

Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. Journal of Hepatology. 2006;44(1Suppl):S6–S9. Available:https://doi.org/10.1016/j.jhep.200 5.11.004

Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, Kirk O, Phillips A, Ledergerber B, Lundgren J, Euro SIDA Study Group. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. The Journal of Infectious Diseases. 2005;192(6):992–1002. Available:https://doi.org/10.1086/432762

Mertz D, Dan G, Jimmy K, Alter MJ. Epidemiology of viral hepatitis and HIV co- infection. J Hepatol. 2017;44(1):S6–9.

Abeni BA, Frank-Peterside N, Agbagwa OE, Adewuyi SA, Cookey TI, Okonko IO. Seropositivity of hepatitis C virus among intending blood donors in Rivers State, Nigeria. Asian Journal of Research and Reports in Gastroenterology. 2020;3(3): 24- 31.

Udeze AO, Okonko IO, Donbraye E, Sule WF, Fadeyi A, Uche LN. Seroprevalence of hepatitis C antibodies amongst blood donors in Ibadan, Southwestern, Nigeria. World Applied Science Journal. 2009;7(8):1023-1028.

Okonko IO, Soleye FA, Nwanze JC, Onoh CC. Detection of HCV antibody among sexually active patients in Abeokuta, Southwestern Nigeria. International Journal of Chemical and Biochemical Sciences. 2012;1(1):14-20.

Sule WF, Odama LE, Daniel AL, Faneye AO, Okonko IO. Prevalence of anti- hepatitis C virus in patients attending Federal Medical Centre (FMC), Lokoja, Kogi State, Nigeria. World Applied Sciences Journal 2009;7(3):371- 377.

Okonko IO, Oyediji TO, Anugweje KC, Adeniji FO, Alli JA. Abraham OA. Detection of HCV antibody among intending blood donors. Nature and Science. 2012;10(1): 53-58.

Okonko I, Shaibu N. Evidence of HIV/HCV coinfection among people living with HIV/AIDS attending Federal Medical Centre, Yenagoa, Nigeria. medRxiv preprint for Health Sciences. Cold Spring Harbor Laboratory BMJ Yale. 2023;1-19. Available:Https://Doi.Org/10.1101/2023.03. 08.23286986

Udeze AO, Bamidele RA, Okonko IO. Sule WF. Hepatitis C virus (HCV) antibody detection among first year students of University of Ilorin, Ilorin, Nigeria. World Journal of Medical Sciences. 2011; 6(3):162–167.

Thomas DL. HIV/HCV coinfection: Comorbidity and clinical implications. Advanced Studies in Medicine. 2005; 5(4C):S352-S355.

Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis. 2001;33(4):562-569. Available:https://www.ncbi.nlm.nih.gov/ pubmed/11462196

Clinical Info HIV. 2023. Considerations for antiretroviral use in patients with coinfection in: Guidelines for the use of antiretroviral agents in adults and adolescents with HIV: Panel's Recommendations Regarding Hepatitis C Virus/HIV Coinfection; 2023. Available:https://clinicalinfo.hiv.gov/en/guid elines/hiv-clinical-guidelines-adult-and- adolescent-arv/coinfections-hepatitis-c- virus-hcv

Accessed on December 08, 2023.

Weber R, Sabin CA, Friis-Moller N, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: The D: A:D study. Arch Intern Med. 2006; 166(15):1632-1641. Available:https://www.ncbi.nlm.nih.gov/pub med/16908797

Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;360(18):1815-1826. Available:https://www.ncbi.nlm.nih.gov/pub med/19339714